Form 8-K - Current report:
SEC Accession No. 0001193125-25-125881
Filing Date
2025-05-23
Accepted
2025-05-23 16:33:24
Documents
14
Period of Report
2025-05-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d891971d8k.htm   iXBRL 8-K 25439
2 EX-99.1 d891971dex991.htm EX-99.1 12126
6 GRAPHIC g891971g0523234022300.jpg GRAPHIC 3997
  Complete submission text file 0001193125-25-125881.txt   165181

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA prta-20250523.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE prta-20250523_lab.xml EX-101.LAB 18690
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prta-20250523_pre.xml EX-101.PRE 11689
17 EXTRACTED XBRL INSTANCE DOCUMENT d891971d8k_htm.xml XML 3833
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 25982953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)